Adaptive Biotechnologies Corp Cash Flow Reinvestment Rate

Latest as of March 2019: 0.81x

Adaptive Biotechnologies Corp cash flow reinvestment rate. Adaptive Biotechnologies Corp (ADPT) has a Cash Flow Reinvestment Rate of 0.81x as of March 2019, reinvesting $226.01 Million (capex $3.83 Million plus investments $-222.18 Million) from operating cash flow of $278.30 Million. Explore ADPT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.81x
(Capex + Investments) / Operating CF

Total Reinvested

$226.01 Million
Capex + Investments

Operating Cash Flow

$278.30 Million
USD

Capital Expenditures

$3.83 Million
USD

Cash Flow Reinvestment Rate of Adaptive Biotechnologies Corp (2019–2019)

Cash flow reinvestment rate of Adaptive Biotechnologies Corp from 2019 to 2019. Historical reinvestment intensity for Adaptive Biotechnologies Corp across 1 annual periods. Explore Adaptive Biotechnologies Corp (ADPT) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Adaptive Biotechnologies Corp Cash Flow Reinvestment Rate by Year (2019–2019)

Adaptive Biotechnologies Corp cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Adaptive Biotechnologies Corp. For the full cash flow conversion analysis, see ADPT cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 2.35x $481.70 Million $205.40 Million $11.20 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow